Kevin Stein
Analyst · Credit Suisse. Your line is now open
Thanks, Nick. Today, I will first provide my regular review of results by key market and profitability of the business for the quarter and then cover outlook and some COVID-19 related topics. Q3 was a challenging quarter against the backdrop of unprecedented slowdown across the commercial aerospace industry and a difficult global economy. In Q3, we saw a significant unfavorable impact on our business from the pandemic as demand for travel declined at a rapid pace and has remained depressed. Despite these headwinds, I am pleased that we were able to achieve an EBITDA as defined margin of 41.5%. Achieving this EBITDA as defined margin was primarily a result of our swift preemptive cost reduction actions and continued focus on our operating strategy. Due to COVID-19, our Q3 GAAP revenues were down approximately 33% versus prior year Q3, and EBITDA as defined, was down 36% versus the prior year. Mike will provide more details on the financials later in the call. Now we will review our revenues by market category. For the remainder of the call, I will provide color commentary on a pro forma basis compared to the prior year period in 2019. That is assuming we own the same mix of businesses in both periods. In the commercial market which makes up close to 65% of our revenue, we will split our discussion into OEM and aftermarket. Our total commercial OEM market revenue declined approximately 43% in Q3 when compared with Q3 of fiscal year 2019. The decline in the quarter did reflect a minimal headwind from the impact of the ongoing 737 MAX production halt. However, the decline is primarily due to the pandemic. Our quarterly commercial OEM bookings were down over 70% versus prior year quarter due to the OEM production rate cuts as a result of COVID-19's impact on commercial aircraft demand. We believe some level of inventory adjustment is likely in this result. The pandemic has caused a significant negative impact on the commercial OEM market, and we believe that we will continue -- and we believe that will continue. We are under the assumption that the demand for our commercial OEM products will be significantly reduced during the remainder of fiscal 2020 due to reductions in OEM production rates and the airlines deferring or canceling new aircraft orders. Longer term, the impact of COVID-19 is fluid and continues to evolve, but we anticipate significant negative impacts on our commercial OEM end markets for some uncertain period of time. Now moving on to our commercial aftermarket business discussion. Total commercial aftermarket revenues declined by approximately 52% over the prior year quarter. In the quarter, the decline in the commercial transport aftermarket was primarily driven by decreased driven by decreased demand in the passenger and interior submarkets. There was also a decline in the commercial transport free market, but at a less impactful rate. Our quarterly commercial aftermarket bookings were down approximately 70% versus prior year quarter results. As a result of the decrease in air travel demand and uncertainties surrounding COVID-19, which is directionally in line with observed revenue passenger mile declines. The rapid and dramatic decline in demand for air travel began late in our Q2 as global restrictions on business and shelter-in-place orders went into effect in response to the pandemic. This led to a significant reduction in global flight capacity in parked aircraft across the world. Certain markets have reopened, some of which have since experienced a resurgence of COVID-19 cases while others, particularly international markets, remain closed or are enforcing quarantines. Airlines have added back some flight capacity. However, recent events have mostly slowed the recovery in the U.S., while the rest of the world seems to be improving slowly. Considering these variables, the shape and speed of the recovery remains uncertain. To touch on a few key points of consideration, global revenue passenger miles are still at unprecedented lows, though off the bottom as a result of the pandemic. IATA recently forecast a 63% decrease in revenue passenger miles in calendar year 202, compared to 2019. Cargo demand was weaker prior to the COVID-19 crisis as FTKs have declined from an all-time high in 2017. However, a loss of passenger belly cargo due to flight cargo and reduced passenger demand could provide some unexpected opportunities. Cargo operations have been impacted to a much lesser extent by COVID-19 than commercial travel has. Business jet utilization data was pointing to stagnant growth before this economic downturn. Now during this pandemic and in the aftermath, the outlook for business jets remains unpredictable as business jet flights are rebounding, but due to personal and leisure travel as opposed to business travel. The sustainability of this trend is difficult to foresee. As we review the future of the commercial aftermarket, a concern may rise around the potential impact from legacy airframe retirements. A wave of retirements could augment the surplus market or used in serviceable material market, which I will refer to as USM. USM has historically been a low risk for TransDigm. We conducted a study a few years back to validate the low-risk of USM for our business and recently did a refresh study that resulted in the same conclusion. We do not see a material exposure to USM at TransDigm. This USM market mainly focuses on high-value parts that have a resale unit price exceeding $5,000 to $10,000, are repairable and typically focused on engine, avionic or landing gear systems. Most of our parts fall well below this $5,000 to $10,000 level, a large percentage are consumable and are not engine-, avionic or landing gear-related. Additionally, our examination of part numbers targeted for USM resale and searches for TransDigm parts for sale in the USM market found an immaterial percentage of our aftermarket parts available for sale in the USM market, validating the low risk of USM for TransDigm. However, we will continue to closely monitor USM to watch for any changes in these historical trends. As the COVID-19 situation is ongoing, the duration and severity of the pandemic are still unclear and longer-term impacts for the commercial aftermarket are hard to predict. We do believe the commercial aftermarket will recover as long as air traffic continues to improve. So that aftermarket recovery is a question of when, not if. Now let me speak about our defense market, which is typically about 35% of our total revenue. The defense market, which includes both OEM and aftermarket revenues, declined by approximately 12% compared to the prior year Q3. As a reminder, we are lapping tough prior year comparisons as our defense revenue accelerated in most of fiscal 2019. Year-to-date, defense bookings were up mid-single digits and have solidly outpaced year-to-date sales. As we have said many times, defense bookings and sales can be sales can be lumpy. This quarter, there were specific timing-related issues out of airborne systems due to delays in international parachute sales and a safety related issue, which delayed shipments at Armtec. We expect our defense business will continue to expand due to the strength of our current order book. Moving to profitability. I'm going to talk primarily about our operating performance or EBITDA as defined. EBITDA as defined of about $424 million for Q3 was down 36% versus prior Q3. EBITDA as defined margin in the quarter was approximately 41.5%. I am pleased that in light of a difficult global economy and commercial aerospace industry, we held the EBITDA as defined margin almost flat with last year. We were able to achieve such an EBITDA as defined margin as a result of our cost mitigation efforts and a consistent focus on our operating strategy. On Esterline, we are now over a year post close. Despite the impact of COVID, the integration continues to progress and exceed our expectations for growth in this largest of TransDigm acquisitions. As we have stated in the past, we will no longer refer to any Esterline specific metrics as these businesses have become part of the fabric of TransDigm. Now let's look at our outlook. As mentioned, we currently expect COVID-19 to continue to have a significant adverse impact on our sales, EBITDA as defined and net income for at least the remainder of fiscal year 2020 under the assumption that the pandemic will negatively impact customer demand and commercial OEM and commercial aftermarket being the most adversely impacted due to the pandemic's impact on air travel worldwide. I do want to reiterate the market conditions we assumed for the second half of fiscal 2020 that we previously disclosed. As a reminder, this was not meant to be guidance but was used for our organizational rightsizing analysis that drove the reduction in force levels implemented to date. We are still utilizing the following with regard to organization sizing needs for the second half of fiscal 2020. Commercial aftermarket declines of 70% to 80%, we will likely perform better here. Commercial OE declines of 25% to 40%, we may perform a bit worse here. Defense growth in the mid-single digits, which is in line with our prior guidance for the defense end market, and this still appears possible. Next, I would like to review our COVID-19 response in more detail. We remain confident in our business model over the long-term and are focused on mitigating the impact of COVID-19 to our business while supporting customers and employees. Additionally, many of our businesses have taken the opportunity to explore new business opportunities by working on developing highly engineered solutions for emerging needs arising from COVID including antiviral, antimicrobial technology, air purification and touchless technologies, to name a few. A cross TransDigm team has been put in place, led by Joel Reiss, one of our most experienced Executive Vice Presidents, to help drive this effort. Now let me provide an update on specific cost saving actions we have taken in response to the reduced demand and uncertainty resulting from the pandemic. We always monitor these costs closely, but even more so in a downturn to ensure we react swiftly and thoughtfully in response to the current environment. We understand that we cannot control the external factors in the downturn, but we remain extremely focused on those items that we can control such as our cost structure. These cost mitigation efforts were previously disclosed and include total workforce reduction of greater than 30% was implemented, including both temporary and permanent reductions. This includes the previous reduction due to the 737 MAX production rate changes and the reduction in force due to COVID-19 implemented in the third quarter of fiscal 2020. This compares favorably to the target provided on the second earnings – second quarter earnings call. Furloughs continue to be utilized to align operations with customer demands until a more permanent view of the market can be realized. We will continue to vigilantly monitor our operations and external events or forecasts and will react quickly, as we always have, to further cost control needs. So let me conclude by stating, I am pleased with the speed at which TransDigm has responded to the pandemic, taking immediate actions to protect employees from the spread of the virus, while also dealing with the harsh reality confronting the broader commercial aerospace industry. The pandemic has been unprecedented, and uncertainty remains about the duration and impact on the pace and shape of any market recovery. However, we have a strong tenured management team that continues to remain poised and ever ready to act quickly and with purpose. We continually monitor the ongoing developments in the commercial aerospace industry and our own business to determine the best course of action. I have the utmost confidence that through our swift cost mitigation efforts and diligent focus on our operating strategy, the company will emerge more strongly from the ongoing weakness in our primary commercial end markets due to an improved cost structure. With that, I would now like to turn it over to our Chief Financial Officer, Mike Lisman.